Dow Up 2.00% Nasdaq Up 1.66%

TrovaGene, Inc. (TROV)

-NasdaqCM
3.76 Down 0.15(3.84%) Feb 12, 4:00PM EST
Prev Close:3.91
Open:3.95
Bid:3.80 x 100
Ask:4.60 x 200
1y Target Est:10.00
Beta:0.582369
Earnings Date:Mar 10 - Mar 14 (Est.)
Day's Range:3.72 - 3.98
52wk Range:2.85 - 13.58
Volume:356,482
Avg Vol (3m):675,287
Market Cap:111.76M
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):400.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.05
Quarterly EPS Est (Dec-15) :-0.25
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback